Indian Nutraceuticals

Indian Nutraceuticals

Along with the growing healthcare industry in India there is an emerging trend in ‘Fast Moving Healthcare Goods (FMHG)’ in India; worldwide known as Nutraceuticals, which are by definition, ingredients with human health benefits beyond basic nutrition. According to Cygnus estimates, nutraceuticals market in 2007 was INR18.75 billion and expected to grow at 20% CAGR to achieve a market size of INR27 billion in 2009. Global nutraceuticals market is estimated at USD120 billion in 2007 growing at 7% (CAGR).The US has been the major market for nutraceuticals with India and China becoming fastest growing markets. Nutraceuticals are gaining acceptance for their ability to address several diseases. Vitamins, Minerals and Nutrients constitute about 85% of the market while antioxidants and anti-agents account for 10% other segments such as herbal extracts occupy 5% of the market, globally. Cygnus has considered nutraceuticals along with functional foods to estimate the total market of nutraceuticals, both global and Indian market. The report aims at recent trend in the industry, global market and its trend, estimates of the future market, growth drivers, critical success factors, issues and challenges, regulatory environment, profiles of major players and their products offering. The report has eight chapters and figures and tables showing major industry data. The report will be useful for industry research analysts, Pharma and other food manufacturing companies, financial institutes, and research institutes interested in broad overview of the industry, market its trend and future trend.

Executive summary 1. Introduction 1.1 Definition 1.2 Classifications 1.2.1 Based on origin of ingredients 1.2.2 Based on nature 1.3 Product classification 1.3.1 Vitamins 1.3.2 Antioxidants 1.3.3 Minerals 1.3.4 Herbals/ botanicals 1.3.5 Proteins 1.3.6 Fibers 2. Market overview 2.1Global Market Overview 2.1.1Introduction 2.1.2 Market scenario 2.1.2.1 Market trends 2.1.3 Major markets 2.1.3.1 US 2.1.3.2 Europe 2.1.3.3 Japan 2.1.3.4 South East Asia 2.1.4 Outlook 2.2 Indian market overview 2.2.1 Introduction 2.2.2 Current Market scenario 2.2.2.1 Market size 2.2.2.2 Market segment 2.2.3 Major companies 2.2.3.1 Glaxosmithkline consumer healthcare 2.2.3.2 Dabur India 2.2.3.3 Cadila Health care 2.2.3.4 EID Parry’s 2.2.3.5 Zandu Pharmaceuticals 2.2.3.6 Himalaya herbal Healthcare
2.2.3.7 Amway 2.2.3.8 Sami labs 2.2.3.9 Elder pharmaceuticals 2.2.3.10 Ranbaxy 2.2.4 Outlook 3. Growth drivers 3.1 Aeging population 3.2 Changing lifestyle 3.3 Increasing medical costs 3.4 High spending power 3.5 Awareness of preventive medicine 3.6 Baby Boomers 3.7 Increasing malnutrition led diseases 4. Issues & challenges 4.1Intense Competition 4.2Functional Dairy Drinks Gaining Momentum 4.3Pharmaceutical and Food Companies Join the Bandwagon 4.4Vitamins-Still a Major Market 4.5Chinese Competition Adverse Affects 5. Critical success factor 5.1Branding 5.2 Pricing 5.3Market promotion 5.4 Channels 6. Major players 6.1Profile of major players 6.1.1 Glaxosmithkline consumer healthcare 6.1.5.1 Company Background 6.1.5.2 Contact Address 6.1.5.3 Management Team 6.1.5.4 Products 6.1.5.5 Strategies 6.1.5.6 Competitive Advantages 6.1.5.7 Financial Details 6.1.5.8 Revenue 6.1.5.9 SWOT analysis 6.1.5.10 Outlook 6.1.2 Dabur India 6.1.2.1 Company Background 6.1.2.2 Contact Address 6.1.2.3 Management Team 6.1.2.4 Products 6.1.2.5 Strategies 6.1.2.6 Competitive Advantages 6.1.2.7 Financial Details 6.1.2.8 Revenue 6.1.2.9 SWOT analysis 6.1.2.10 Outlook 6.1.3 Cadila Health care 6.1.3.1 Company Background 6.1.3.2 Contact Address 6.1.3.3 Management Team 6.1.3.4 Products 6.1.3.5 Strategies 6.1.3.6 Competitive Advantages 6.1.3.7 Financial Details 6.1.3.8 Revenue 6.1.3.9 SWOT analysis 6.1.3.10 Outlook 6.1.4 EID Parry’s 6.1.4.1 Company Background 6.1.4.2 Contact Address 6.1.4.3 Management Team 6.1.4.4 Products 6.1.4.5 Strategies 6.1.4.6 Competitive Advantages 6.1.4.7 Financial Details 6.1.4.8 Revenue 6.1.4.9 SWOT analysis 6.1.4.10 Outlook 6.1.5 Zandu Pharmaceuticals 6.1.5.1 Company Background 6.1.5.2 Contact Address 6.1.5.3 Management Team 6.1.5.4 Products 6.1.5.5 Strategies 6.1.5.6 Competitive Advantages 6.1.5.7 Financial Details 6.1.5.8 Revenue 6.1.5.9 SWOT analysis 6.1.5.10 Outlook 6.1.6 Himalaya herbal Healthcare 6.1.6.1 Company Background 6.1.6.2 Contact Address 6.1.6.3 Management Team 6.1.6.4 Products 6.1.6.5 Strategies 6.1.6.6 Competitive Advantages 6.1.6.7 Financial Details 6.1.6.8 Revenue 6.1.6.9 SWOT analysis 6.1.6.10 Outlook 6.1.7 Amway 6.1.7.1 Company Background 6.1.7.2 Contact Address 6.1.7.3 Management Team 6.1.7.4 Products 6.1.7.5 Strategies 6.1.7.6 Competitive Advantages 6.1.7.7 Financial Details 6.1.7.8 Revenue 6.1.7.9 SWOT analysis 6.1.7.10 Outlook 6.1.8 Sami labs 6.1.8.1 Company Background 6.1.8.2 Contact Address 6.1.8.3 Management Team 6.1.8.4 Products 6.1.8.5 Strategies 6.1.8.6 Competitive Advantages 6.1.8.7 Financial Details 6.1.8.8 Revenue 6.1.8.9 SWOT analysis 6.1.8.10 Outlook 6.1.9 Elder pharmaceuticals 6.1.9.1 Company Background 6.1.9.2 Contact Address 6.1.9.3 Management Team 6.1.9.4 Products 6.1.9.5 Strategies 6.1.9.6 Competitive Advantages 6.1.9.7 Financial Details 6.1.9.8 Revenue 6.1.9.9 SWOT analysis 6.1.9.10 Outlook 6.1.10 Ranbaxy 6.2.10.1 Company Background 6.2.10.2 Contact Address 6.2.10.3 Management Team 6.2.10.4 Products 6.2.10.5 Strategies 6.2.10.6 Competitive Advantages 6.2.10.7 Financial Details 6.2.10.8 Revenue 6.2.10.9 SWOT analysis 6.2.10.10 Outlook 6.2 Profile of other players 6.2.1 Raptakos 6.2.1.1 Company Background 6.2.1.2 Products 6.2.1.3 Outlook k 6.2.2 Paras 6.2.2.1 Company Background 6.2.2.2 Products 6.2.2.3 Outlook 6.2.3 Medreich 6.2.3.1 Company Background 6.2.3.2 Products 6.2.3.3 Outlook 6.2.4 Tablets India 6.2.4.1 Company Background 6.2.4.2 Products 6.2.4.3 Outlook 7. Regulatory Environment 7.1 US 7.2 Europe 7.3 Japan 7.4 India 8. Future outlook